Fundraising Fox
HotHouse Therapeutics
Norwich, GB · 13 employees on LinkedIn · 4 known investors
Find your way into HotHouse Therapeutics
Sign up to see every warm intro you have to HotHouse Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the HotHouse Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
HotHouse Therapeutics uses artificial intelligence and synthetic biology to reprogram plant biosynthetic pathways to create novel pharmaceutical compounds not achievable through traditional chemical synthesis.
Founders & leadership
PA
Professor Anne Osbourn OBE FRS FLSChief Science Officer
DD
Dr David SheppardChief Executive Officer
Investors · 4
Frequently asked questions
- What does HotHouse Therapeutics do?
- HotHouse Therapeutics uses artificial intelligence and synthetic biology to reprogram plant biosynthetic pathways to create novel pharmaceutical compounds not achievable through traditional chemical synthesis.
- Who founded HotHouse Therapeutics?
- HotHouse Therapeutics was founded by Professor Anne Osbourn OBE FRS FLS.
- Who are HotHouse Therapeutics's investors?
- HotHouse Therapeutics's investors include Cambridge Angels group, Future Planet Capital, Twin Path Ventures, UK Innovation & Science Seed Fund.
- Where is HotHouse Therapeutics headquartered?
- HotHouse Therapeutics is headquartered in Norwich, GB.